Subcutaneous Immunoglobulin Maintains HRQoL Among Patients With CIDP

In patients with CIDP, health-related quality of life with IVIg was also maintained with facilitated subcutaneous immunoglobulin treatment.

Related Keywords

Phoenix ,Arizona ,United States , ,American Association Of Neuromuscular Electrodiagnostic Medicine ,Electrodiagnostic Medicine ,Annual Meeting ,Rasch Built Overall Disability Scale ,Item Short Form ,Treatment Satisfaction Questionnaire ,